Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T16:21:22.984Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:21:22.984Z.

Quote observation: 2026-10-06T16:20:19.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 304,207,327
Total debt · period ending 2026-06-30: 762,000
Cash · period ending 2026-06-30: 179,972,000
TTM operating EBITDA · period ending 2026-06-30: -50,711,000

FMP input reference: 16291309013886a388882617e5d80f34fb5e9972494eca64a5e5fc74bed8c75f

EV/Sales|P/E Ratio|EBITDA|All Metrics

BNTC EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

N/A

EV/EBITDA RATIO AVG 3Y

N/A

EV/EBITDA RATIO AVG 5Y

N/A

EV/EBITDA RATIO AVG 10Y

N/A

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

BNTC Competitors' EV/EBITDA Ratio

BNTC

Benitec Biopharma Inc.

Current

Market Cap

$304.21M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LRMR

Larimar Therapeutics, Inc.

vs BNTC

Market Cap

$296.59M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MOBI

Mobia Medical, Inc. Common Stock

vs BNTC

Market Cap

$308.22M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BBOT

BridgeBio Oncology Therapeutics Inc.

vs BNTC

Market Cap

$287.88M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABEO

Abeona Therapeutics Inc.

vs BNTC

Market Cap

$288.21M

EV/EBITDA Ratio

N/A

TTM Avg

18.83x

3Y Avg

18.83x

5Y Avg

18.83x

SGMT

Sagimet Biosciences Inc.

vs BNTC

Market Cap

$288.33M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LAB

Standard BioTools Inc.

vs BNTC

Market Cap

$286.75M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FULC

Fulcrum Therapeutics, Inc.

vs BNTC

Market Cap

$282.68M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INDP

Indaptus Therapeutics, Inc.

vs BNTC

Market Cap

$285.37M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CCCC

C4 Therapeutics, Inc.

vs BNTC

Market Cap

$319.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Benitec Biopharma Inc. (BNTC)	$304.21M	N/A	N/A	N/A	N/A
Larimar Therapeutics, Inc. (LRMR)vs ›	$296.59M	N/A	N/A	N/A	N/A
Mobia Medical, Inc. Common Stock (MOBI)vs ›	$308.22M	N/A	N/A	N/A	N/A
BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›	$287.88M	N/A	N/A	N/A	N/A
Abeona Therapeutics Inc. (ABEO)vs ›	$288.21M	N/A	18.83x	18.83x	18.83x
Sagimet Biosciences Inc. (SGMT)vs ›	$288.33M	N/A	N/A	N/A	N/A
Standard BioTools Inc. (LAB)vs ›	$286.75M	N/A	N/A	N/A	N/A
Fulcrum Therapeutics, Inc. (FULC)vs ›	$282.68M	N/A	N/A	N/A	N/A
Indaptus Therapeutics, Inc. (INDP)vs ›	$285.37M	N/A	N/A	N/A	N/A
C4 Therapeutics, Inc. (CCCC)vs ›	$319.54M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

BNTC EV/EBITDA Ratio History

DATE	EV/EBITDA RATIO
2019-09-30	8.08x
2019-09-27	10.64x
2019-09-26	9.86x
2019-09-25	8.90x
2019-09-24	9.86x
2019-09-23	9.36x
2019-09-20	10.26x
2019-09-19	7.66x
2019-09-18	10.26x
2019-09-17	12.26x
2019-09-16	6.06x
2019-09-13	5.86x
2019-09-12	5.96x
2019-09-11	5.68x
2019-09-10	6.36x
2019-09-09	6.08x
2019-09-06	6.82x
2019-09-05	7.20x
2019-09-04	7.26x
2019-09-03	7.86x
2019-08-30	8.26x
2019-08-29	7.46x
2019-08-28	7.46x
2019-08-27	8.56x
2019-08-26	8.66x
2019-08-23	8.00x
2019-08-22	7.68x
2019-08-21	7.68x
2019-08-20	7.66x
2019-08-19	9.36x
2019-08-16	8.86x
2019-08-15	8.86x
2019-08-14	7.46x
2019-08-13	8.46x
2019-08-12	9.46x
2019-08-09	9.38x
2019-08-08	9.46x
2019-08-07	9.06x
2019-08-06	9.48x
2019-08-05	9.82x
2019-08-02	9.74x
2019-08-01	10.26x
2019-07-31	10.86x
2019-07-30	7.06x
2019-07-29	6.66x
2019-07-26	4.52x
2019-07-25	5.82x
2019-07-24	7.26x
2019-07-23	7.44x
2019-07-22	7.42x
2019-07-19	7.76x
2019-07-18	7.76x
2019-07-17	7.76x
2019-07-16	7.76x
2019-07-15	8.18x
2019-07-12	9.06x
2019-07-11	9.06x
2019-07-10	8.66x
2019-07-09	8.60x
2019-07-08	8.60x
2019-07-05	9.26x
2019-07-03	8.24x
2019-07-02	8.24x
2019-07-01	8.84x
2019-06-28	15.40x
2019-06-27	15.05x
2019-06-26	15.42x
2019-06-25	14.40x
2019-06-24	15.69x
2019-06-21	16.45x
2019-06-20	17.69x
2019-06-19	16.45x
2019-06-18	17.89x
2019-06-17	16.60x
2019-06-14	17.40x
2019-06-13	17.40x
2019-06-12	18.51x
2019-06-11	18.51x
2019-06-10	20.57x
2019-06-07	20.15x
2019-06-06	21.39x
2019-06-05	32.49x
2019-06-04	34.47x
2019-06-03	32.91x
2019-05-31	32.91x
2019-05-30	32.91x
2019-05-29	36.81x
2019-05-28	34.76x
2019-05-24	34.76x
2019-05-23	35.37x
2019-05-22	35.37x
2019-05-21	37.84x
2019-05-20	35.37x
2019-05-17	38.05x
2019-05-16	40.52x
2019-05-15	40.52x
2019-05-14	39.36x
2019-05-13	40.37x
2019-05-10	38.25x
2019-05-09	39.08x
2019-05-08	39.90x
2019-05-07	39.94x
2019-05-06	39.71x
2019-05-03	39.28x
2019-05-02	39.73x
2019-05-01	39.08x
2019-04-30	41.13x
2019-04-29	38.68x
2019-04-26	39.51x
2019-04-25	35.56x
2019-04-24	38.05x
2019-04-23	35.99x
2019-04-22	35.78x
2019-04-18	35.99x
2019-04-17	37.22x
2019-04-16	36.73x
2019-04-15	41.11x
2019-04-12	42.24x
2019-04-11	44.22x
2019-04-10	44.22x
2019-04-09	44.83x
2019-04-08	42.78x
2019-04-05	40.72x
2019-04-04	39.69x
2019-04-03	39.08x
2019-04-02	39.12x
2019-04-01	37.64x
2019-03-29	33.72x
2019-03-28	31.42x
2019-03-27	29.73x
2019-03-26	29.36x
2019-03-25	30.61x
2019-03-22	33.52x
2019-03-21	34.49x
2019-03-20	34.11x
2019-03-19	33.91x
2019-03-18	31.58x
2019-03-15	31.00x
2019-03-14	32.16x
2019-03-13	32.16x
2019-03-12	36.24x
2019-03-11	33.79x
2019-03-08	34.98x
2019-03-07	34.49x
2019-03-06	35.08x
2019-03-05	34.69x
2019-03-04	38.19x
2019-03-01	31.58x
2019-02-28	30.80x
2019-02-27	28.47x
2019-02-26	28.47x
2019-02-25	28.08x
2019-02-22	27.69x
2019-02-21	25.94x
2019-02-20	28.04x
2019-02-19	28.47x
2019-02-15	29.25x
2019-02-14	31.42x
2019-02-13	30.67x
2019-02-12	28.66x
2019-02-11	23.32x
2019-02-08	22.68x
2019-02-07	23.80x
2019-02-06	24.00x
2019-02-05	23.22x
2019-02-04	23.22x
2019-02-01	24.58x
2019-01-31	22.71x
2019-01-30	22.71x
2019-01-29	22.71x
2019-01-28	24.08x
2019-01-25	24.08x
2019-01-24	25.09x
2019-01-23	25.09x
2019-01-22	23.36x
2019-01-18	23.22x
2019-01-17	24.97x
2019-01-16	24.97x
2019-01-15	22.83x
2019-01-14	23.03x
2019-01-11	23.80x
2019-01-10	23.22x
2019-01-09	23.22x
2019-01-08	22.44x
2019-01-07	22.83x
2019-01-04	22.87x
2019-01-03	24.66x
2019-01-02	24.78x

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics

EV/EBITDA Ratio: N/A

BNTC EV/EBITDA Ratio Chart

BNTC EV/EBITDA Ratio Metrics

BNTC Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

BNTC EV/EBITDA Ratio History

Related Metrics